Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia, the RALLY study.
For more information, please visit www.RALLYStudy.com or www.clinicaltrials.gov (NCT04508621).
- Home
- Investors
- SEC Filings
- All SEC Filings
All SEC Filings
| Date | Form | Description | Docs | XBRL | Pages |
| 01/29/14 | 8-K | Current report filing |
|
5 | |
| 01/28/14 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
18 | |
| 01/24/14 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
79 | |
| 01/24/14 | 8-K | Current report filing |
|
46 | |
| 01/23/14 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
79 | |
| 01/22/14 | 8-K | Current report filing |
|
3 | |
| 01/14/14 | 8-K | Current report filing |
|
3 | |
| 01/08/14 | EFFECT | Notice of Effectiveness |
|
1 | |
| 01/07/14 | 8-K | Current report filing |
|
33 | |
| 01/06/14 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 |
